Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.60B | 2.90B | 3.21B | 3.07B | 2.11B |
Gross Profit | 34.18M | 316.20M | 793.27M | 813.18M | 34.21M |
EBITDA | -36.64M | 306.48M | 813.12M | 695.48M | 147.50M |
Net Income | -505.39M | -152.34M | 201.56M | 379.24M | -241.78M |
Balance Sheet | |||||
Total Assets | 5.41B | 6.27B | 5.85B | 4.04B | 2.85B |
Cash, Cash Equivalents and Short-Term Investments | 8.10M | 62.93M | 224.06M | 413.26M | 14.54M |
Total Debt | 3.40B | 3.69B | 3.14B | 2.56B | 2.18B |
Total Liabilities | 5.05B | 5.35B | 4.79B | 3.21B | 2.83B |
Stockholders Equity | 403.22M | 908.10M | 1.06B | 822.07M | 16.98M |
Cash Flow | |||||
Free Cash Flow | -111.57M | 5.69M | -58.83M | -228.16M | -52.82M |
Operating Cash Flow | -103.33M | 224.47M | 715.30M | 435.30M | 6.58M |
Investing Cash Flow | 280.47M | -718.51M | -1.16B | -650.26M | -57.80M |
Financing Cash Flow | -232.57M | 332.57M | 272.77M | 593.86M | 55.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | HK$4.32B | 7.44 | 9.36% | 6.57% | -3.73% | 6.09% | |
61 Neutral | $10.24B | 6.18 | 0.71% | 2.90% | 3.45% | -36.02% | |
58 Neutral | HK$2.12B | 2.79 | 13.87% | ― | 9.20% | 213.87% | |
57 Neutral | HK$807.23M | 8.80 | 4.75% | 2.84% | -13.75% | -56.14% | |
54 Neutral | HK$1.18B | 16.02 | 2.75% | 3.76% | -11.89% | -69.45% | |
45 Neutral | HK$204.95M | ― | -112.79% | ― | -22.72% | -212.73% | |
― | €18.07M | ― | -13.04% | ― | ― | ― |
Ko Yo Chemical (Group) Limited has issued a profit warning, anticipating a loss of approximately RMB185.8 million for the first half of 2025, an increase of RMB56.1 million compared to the previous year. This increased loss is attributed to a decline in product market prices, which has negatively impacted the gross profit margin. The announcement advises shareholders and potential investors to exercise caution when dealing with the company’s shares.
Ko Yo Chemical (Group) Limited has issued a supplemental announcement regarding its share option scheme as detailed in its 2024 annual report. The company disclosed that as of the end of 2024, it had 171,492,259 share options available for grant, with a total of 550,304,259 shares available for issue under the scheme, representing approximately 9.1% of the issued shares. The announcement also highlighted restrictions on the number of shares that can be granted to participants within a 12-month period without shareholder approval, ensuring controlled distribution of share options.
Ko Yo Chemical (Group) Limited has announced a board meeting scheduled for August 29, 2025, to discuss several key matters, including the approval of the company’s consolidated unaudited interim results for the first half of 2025, consideration of an interim dividend, and the potential closure of the register of members. The outcomes of this meeting could influence the company’s financial strategy and shareholder relations, impacting its market positioning and stakeholder interests.
Ko Yo Chemical (Group) Limited has announced updates regarding its financial strategies and operational adjustments to address going concern issues. The company has successfully renewed or restructured significant bank loans and negotiated with bondholders to defer repayments, while also engaging with the Sichuan government for support in the natural gas sector. Additionally, the company is optimizing its sales model and advancing production projects, which are expected to enhance its market positioning and operational efficiency.
Ko Yo Chemical (Group) Limited announced the results of its Annual General Meeting (AGM) held on 30 May 2025, where all proposed resolutions were passed unanimously by shareholders. The resolutions included the adoption of financial statements, re-election of directors, authorization of directors’ remuneration, re-appointment of auditors, and granting of mandates for share issuance and repurchase. This successful AGM reflects strong shareholder support and positions the company for continued operational stability and strategic growth.